Original Biotinylated Human Hla-a*31:01&b2m&egfr L858r (hvkitdfgr) Monomer Protein (mhc-hm485b) 30% Off - Today Only [orMy8DZj]

Biotinylated Human HLA-A*31:01&B2M&EGFR L858R Monomer Protein

Introducing the Biotinylated Human HLA-A*31:01&B2M&EGFR L858R Monomer Protein, a cutting-edge research tool designed for in-depth immunological and molecular studies. This monomer protein is a powerful component for understanding antigen presentation and immune response mechanisms. With its biotinylated modification, it offers enhanced binding capabilities, making it an ideal choice for various experimental applications.

• High purity ensures reliable results in your research
• Biological activity maintained for effective use
• Convenient for use in flow cytometry, ELISA, and other applications

Product Properties and Specifications

This product is meticulously prepared with high-grade recombinant technology, ensuring its high purity and stability. The monomer protein is specifically engineered to contain the EGFR L858R mutation, making it an excellent model for studying EGFR-driven diseases. The protein is also biotinylated, which not only improves its binding affinity but also enhances its compatibility with a variety of detection methods.

• Recombinant technology for high purity and stability
• Contains EGFR L858R mutation for accurate disease modeling
• Biotinylated for improved binding affinity and compatibility with multiple detection methods

Applications and Benefits

The Biotinylated Human HLA-A*31:01&B2M&EGFR L858R Monomer Protein is an indispensable tool for researchers investigating cancer immunology, especially those focused on EGFR-driven cancers. Its versatility allows for a wide range of applications, including in vitro diagnostics, therapeutic antibody development, and immunotherapy research. With this product, scientists can gain valuable insights into the complex interactions between HLA-A*31:01, B2M, and EGFR L858R, leading to advancements in personalized medicine and targeted therapies.

• Enables accurate study of HLA-A*31:01, B2M, and EGFR L858R interactions
• Facilitates research in cancer immunology and personalized medicine
• Supports the development of novel therapeutic strategies for EGFR-driven diseases